| 1 |
Blázquez-Encinas R, Moreno-Montilla MT, García-Vioque V, Gracia-Navarro F, Alors-Pérez E, Pedraza-Arevalo S, Ibáñez-Costa A, Castaño JP. The uprise of RNA biology in neuroendocrine neoplasms: altered splicing and RNA species unveil translational opportunities. Rev Endocr Metab Disord 2023;24:267-82. [PMID: 36418657 DOI: 10.1007/s11154-022-09771-4] [Reference Citation Analysis]
|
| 2 |
Honan KA, Hassan S, Deswal A, Herrmann J, Song J, Monlezun D, Halperin D, Mahvash A, Dasari A, Koutroumpakis E, Akay M, Balanescu DV, de Armas IS, Patel M, Nathan S, Kar B, Marmagkiolis K, Lopez-Mattei J, Patel J, Gregoric I, Yao J, Iliescu CA. Bioprosthetic valve monitoring in patients with carcinoid heart disease. Front Cardiovasc Med 2022;9:1072890. [PMID: 36712267 DOI: 10.3389/fcvm.2022.1072890] [Reference Citation Analysis]
|
| 3 |
Müller-debus C, Wellner U, Keck T. Sporadische duodenale neuroendokrine Neoplasien. Springer Reference Medizin 2023. [DOI: 10.1007/978-3-662-63317-5_41] [Reference Citation Analysis]
|
| 4 |
Castle JT, Levy BE, Chauhan A. Pediatric Neuroendocrine Neoplasms: Rare Malignancies with Incredible Variability. Cancers (Basel) 2022;14:5049. [PMID: 36291833 DOI: 10.3390/cancers14205049] [Reference Citation Analysis]
|
| 5 |
Nelson HA, Frank EL. Quantification of 5-Hydroxyindoleacetic Acid in Urine by Ultra-performance Liquid Chromatography Tandem Mass Spectrometry. Methods Mol Biol 2022;2546:195-204. [PMID: 36127590 DOI: 10.1007/978-1-0716-2565-1_18] [Reference Citation Analysis]
|
| 6 |
Fernandes CJ, Leung G, Eads JR, Katona BW. Gastroenteropancreatic Neuroendocrine Tumors. Gastroenterol Clin North Am 2022;51:625-47. [PMID: 36153114 DOI: 10.1016/j.gtc.2022.06.002] [Reference Citation Analysis]
|
| 7 |
Pope EM, Somers KE. Chronic venulectasias secondary to persistent flushing in the setting of a metastatic well-differentiated neuroendocrine tumor. JAAD Case Rep 2022;26:30-1. [PMID: 35865723 DOI: 10.1016/j.jdcr.2022.06.002] [Reference Citation Analysis]
|
| 8 |
Gagliardo CM, Noto D, Giammanco A, Savoja A, Panzica M, Lavatura G, Presti RL, Cefalù AB, Averna M. An unusual case of chronic diarrhea: a case report. Intern Emerg Med 2022. [PMID: 35908014 DOI: 10.1007/s11739-022-03055-0] [Reference Citation Analysis]
|
| 9 |
Kostiainen I, Karppinen N, Simonen P, Rosengård-Bärlund M, Lindén R, Tarkkanen M, Gordin D, Rapola J, Schalin-Jäntti C, Matikainen N. Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours. Endocrine 2022. [PMID: 35536452 DOI: 10.1007/s12020-022-03065-0] [Reference Citation Analysis]
|
| 10 |
Crafa A, Condorelli RA, Cannarella R, Aversa A, Calogero AE, La Vignera S. Physical Examination for Endocrine Diseases: Does It Still Play a Role? J Clin Med 2022;11:2598. [PMID: 35566722 DOI: 10.3390/jcm11092598] [Reference Citation Analysis]
|
| 11 |
Fang JM, Li J, Shi J. An update on the diagnosis of gastroenteropancreatic neuroendocrine neoplasms. World J Gastroenterol 2022; 28(10): 1009-1023 [DOI: 10.3748/wjg.v28.i10.1009] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 12 |
Magi L, Rinzivillo M, Panzuto F. What Gastroenterologists Should Know about Carcinoid Syndrome. Gastroenterology Insights 2022;13:127-38. [DOI: 10.3390/gastroent13010014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Guzel T, Mirowska-Guzel D. The Role of Serotonin Neurotransmission in Gastrointestinal Tract and Pharmacotherapy. Molecules 2022;27. [PMID: 35268781 DOI: 10.3390/molecules27051680] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 14 |
Lee L, Ramos-Alvarez I, Jensen RT. Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies. Cancers (Basel) 2022;14:1250. [PMID: 35267558 DOI: 10.3390/cancers14051250] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 15 |
Maxwell JE, Naraev B, Halperin DM, Choti MA, Halfdanarson TR. Shifting Paradigms in the Pathophysiology and Treatment of Carcinoid Crisis. Ann Surg Oncol 2022. [PMID: 35165817 DOI: 10.1245/s10434-022-11371-0] [Reference Citation Analysis]
|
| 16 |
Cope J, Srirajaskanthan R. Rectal Neuroendocrine Neoplasms: Why Is There a Global Variation? Curr Oncol Rep 2022. [PMID: 35084662 DOI: 10.1007/s11912-021-01172-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 17 |
Müller-debus C, Wellner U, Keck T. Sporadische duodenale neuroendokrine Neoplasien. Springer Reference Medizin 2022. [DOI: 10.1007/978-3-662-61724-3_41-1] [Reference Citation Analysis]
|
| 18 |
Colao A, Pivonello C, Modica R, Bottiglieri F. Carcinoid Syndrome. Endocrine Pathology 2022. [DOI: 10.1007/978-3-030-62345-6_5102] [Reference Citation Analysis]
|
| 19 |
Abraham JR, Torline E, Fentanes E. Focus on POCUS: Carcinoid Heart Disease Found with Point-of-Care Ultrasound during Basic Physical Exam. CASE 2021;5:380-383. [DOI: 10.1016/j.case.2021.09.002] [Reference Citation Analysis]
|
| 20 |
Barazeghi E, Hellman P, Norlén O, Westin G, Stålberg P. EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine. Sci Rep 2021;11:22733. [PMID: 34815475 DOI: 10.1038/s41598-021-02181-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 21 |
Alvarez-Villegas D, Giménez-Milà M, Sbraga F, Camprubí I, Gil A, Valchanov K, Shayan H, Castillo J, Weiner MM. Dealing With the Right Side: Carcinoid Heart Disease. J Cardiothorac Vasc Anesth 2021:S1053-0770(21)00950-2. [PMID: 34863651 DOI: 10.1053/j.jvca.2021.10.030] [Reference Citation Analysis]
|
| 22 |
Тyshchenko АМ, Smachylo RM, Mushenko EV, Ivanenko OV. Carcinoid of small intestine - the cause of gastro-intestinal hemorrhage and acute ileus. KH 2021;88:94-97. [DOI: 10.26779/2522-1396.2021.5-6.94] [Reference Citation Analysis]
|
| 23 |
Koch C, Koca E, Filmann N, Husmann G, Bojunga J. Time from first tumor manifestation to diagnosis in patients with GEP-NET: Results from a large German tertiary referral center. Medicine (Baltimore) 2021;100:e27276. [PMID: 34664885 DOI: 10.1097/MD.0000000000027276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 24 |
Famerée L, Van Lier C, Borbath I, Yildiz H, Lemaire J, Baeck M. Misleading clinical presentation of carcinoid syndrome. Acta Gastroenterol Belg 2021;84:501-3. [PMID: 34599576 DOI: 10.51821/84.3.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 25 |
Crafa A, Calogero AE, Cannarella R, Mongioi' LM, Condorelli RA, Greco EA, Aversa A, La Vignera S. The Burden of Hormonal Disorders: A Worldwide Overview With a Particular Look in Italy. Front Endocrinol (Lausanne) 2021;12:694325. [PMID: 34220719 DOI: 10.3389/fendo.2021.694325] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 26 |
Spada F, Rossi RE, Kara E, Laffi A, Massironi S, Rubino M, Grimaldi F, Bhoori S, Fazio N. Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management. Pharmaceuticals (Basel) 2021;14:539. [PMID: 34199977 DOI: 10.3390/ph14060539] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 27 |
Ratnayake G, Toumpanakis C. Carcinoid syndrome and its sequelae. Current Opinion in Endocrine and Metabolic Research 2021;18:111-7. [DOI: 10.1016/j.coemr.2021.02.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 28 |
Kalra S, Bhattacharya S, Rawal P. Hepatocrinology. Med Sci (Basel) 2021;9:39. [PMID: 34205986 DOI: 10.3390/medsci9020039] [Reference Citation Analysis]
|
| 29 |
Froelich MF, Schnitzer ML, Holzgreve A, Gassert FG, Gresser E, Overhoff D, Schwarze V, Fabritius MP, Nörenberg D, von Münchhausen N, Hokamp NG, Auernhammer CJ, Ilhan H, Todica A, Rübenthaler J. Cost-Effectiveness Analysis of 68Ga DOTA-TATE PET/CT, 111In-Pentetreotide SPECT/CT and CT for Diagnostic Workup of Neuroendocrine Tumors. Diagnostics (Basel) 2021;11:334. [PMID: 33670457 DOI: 10.3390/diagnostics11020334] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 30 |
Fragkou PC, Papadopoulos IA, Papadopoulos A, Kontoveros EA, Kaltsas G, Vassilara F. Rare Presentation of a Metastatic Pancreatic Neuroendocrine Neoplasm Presenting with Atrial Flutter. Eur J Case Rep Intern Med 2021;8:002216. [PMID: 33585343 DOI: 10.12890/2021_002216] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 31 |
Pitchumoni CS, Chaubal A, Desai G. Gastric Tumors (Other than Adenocarcinoma). Geriatric Gastroenterology 2021. [DOI: 10.1007/978-3-030-30192-7_117] [Reference Citation Analysis]
|
| 32 |
Gangi A, Howe JR. Carcinoid Crisis. Endocrine Surgery Comprehensive Board Exam Guide 2021. [DOI: 10.1007/978-3-030-84737-1_43] [Reference Citation Analysis]
|
| 33 |
Pitchumoni CS, Chaubal A, Desai G. Gastric Tumors (Other than Adenocarcinoma). Geriatric Gastroenterology 2021. [DOI: 10.1007/978-3-319-90761-1_117-1] [Reference Citation Analysis]
|
| 34 |
Ramakrishnan N, Ahn SH, Jialal I. Gastroenteropancreatic neuroendocrine tumors. Handbook of Diagnostic Endocrinology 2021. [DOI: 10.1016/b978-0-12-818277-2.00006-6] [Reference Citation Analysis]
|
| 35 |
Rose JB, Zheng-pywell R. Perioperative Management. Neuroendocrine Tumors 2021. [DOI: 10.1007/978-3-030-62241-1_4] [Reference Citation Analysis]
|
| 36 |
Fanciulli G, Ruggeri RM, Grossrubatscher E, Calzo FL, Wood TD, Faggiano A, Isidori A, Colao A; NIKE. Serotonin pathway in carcinoid syndrome: Clinical, diagnostic, prognostic and therapeutic implications. Rev Endocr Metab Disord 2020;21:599-612. [PMID: 32152781 DOI: 10.1007/s11154-020-09547-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 37 |
Rindi G, Wiedenmann B. Neuroendocrine neoplasia of the gastrointestinal tract revisited: towards precision medicine. Nat Rev Endocrinol 2020;16:590-607. [PMID: 32839579 DOI: 10.1038/s41574-020-0391-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 38 |
Deguelte S, Perrier M, Hammoutene C, Cadiot G, Kianmanesh R. Surgery and Perioperative Management in Small Intestinal Neuroendocrine Tumors. J Clin Med. 2020;9. [PMID: 32708330 DOI: 10.3390/jcm9072319] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 39 |
Del Olmo-García MI, Muros MA, López-de-la-Torre M, Agudelo M, Bello P, Soriano JM, Merino-Torres JF. Prevention and Management of Hormonal Crisis during Theragnosis with LU-DOTA-TATE in Neuroendocrine Tumors. A Systematic Review and Approach Proposal. J Clin Med 2020;9:E2203. [PMID: 32664679 DOI: 10.3390/jcm9072203] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 40 |
Peri M, Fazio N. Clinical Evaluation of Everolimus in the Treatment of Neuroendocrine Tumors of the Lung: Patient Selection and Special Considerations. A Systematic and Critical Review of the Literature. Lung Cancer (Auckl) 2020;11:41-52. [PMID: 32753993 DOI: 10.2147/LCTT.S249928] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 41 |
Soeiro P, Martins H, Silva R, Moreira AP. Complete remission of inoperable hepatic and bone metastases due to neuroendocrine pancreatic tumour 3 years after peptide receptor radionucleotide therapy. BMJ Case Rep 2020;13:e233263. [PMID: 32234855 DOI: 10.1136/bcr-2019-233263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 42 |
Gade AK, Olariu E, Douthit NT. Carcinoid Syndrome: A Review. Cureus. 2020;12:e7186. [PMID: 32257725 DOI: 10.7759/cureus.7186] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 43 |
Baldelli R, Renzelli V, Rota F, Di Giacinto P, Bianchi A, Rizza L, Zuppi P. La sindrome da carcinoide. L'Endocrinologo 2020;21:5-9. [DOI: 10.1007/s40619-020-00653-y] [Reference Citation Analysis]
|
| 44 |
Clement D, Ramage J, Srirajaskanthan R. Update on Pathophysiology, Treatment, and Complications of Carcinoid Syndrome. J Oncol 2020;2020:8341426. [PMID: 32322270 DOI: 10.1155/2020/8341426] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 45 |
Manni A, Quarde A. Pancreatic Gland Signs. Endocrine Pathophysiology 2020. [DOI: 10.1007/978-3-030-49872-6_4] [Reference Citation Analysis]
|
| 46 |
Colao A, Pivonello C, Modica R, Bottiglieri F. Carcinoid Syndrome. Encyclopedia of Pathology 2020. [DOI: 10.1007/978-3-319-28845-1_5102-1] [Reference Citation Analysis]
|
| 47 |
Lee L, Ito T, Jensen RT. Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies. Expert Rev Anticancer Ther. 2019;19:1029-1050. [PMID: 31738624 DOI: 10.1080/14737140.2019.1693893] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 48 |
Herrera-Martínez AD, Hofland J, Hofland LJ, Brabander T, Eskens FALM, Gálvez Moreno MA, Luque RM, Castaño JP, de Herder WW, Feelders RA. Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives. Drugs 2019;79:21-42. [PMID: 30560479 DOI: 10.1007/s40265-018-1033-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 49 |
Naraev BG, Halland M, Halperin DM, Purvis AJ, OʼDorisio TM, Halfdanarson TR. Management of Diarrhea in Patients With Carcinoid Syndrome. Pancreas 2019;48:961-72. [PMID: 31425482 DOI: 10.1097/MPA.0000000000001384] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 50 |
Principe DR, Raicu A, Bergsten TM, Rubin J, Hagen C. Ileal carcinoid tumor represents after prolonged remission as a solitary breast mass. J Surg Case Rep 2019;2019:rjz171. [PMID: 31214312 DOI: 10.1093/jscr/rjz171] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 51 |
Moody TW, Ramos-Alvarez I, Jensen RT. Neuropeptide G Protein-Coupled Receptors as Oncotargets. Front Endocrinol (Lausanne) 2018;9:345. [PMID: 30008698 DOI: 10.3389/fendo.2018.00345] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 52 |
Lee L, Ito T, Jensen RT. Everolimus in the treatment of neuroendocrine tumors: efficacy, side-effects, resistance, and factors affecting its place in the treatment sequence. Expert Opin Pharmacother 2018;19:909-28. [PMID: 29757017 DOI: 10.1080/14656566.2018.1476492] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 53 |
Gawad NA, Kohner A, Ali T, Hofstetter W, Valentine A. Valproic Acid Attenuates Postoperative Psychosis Following Aggressive Resection of an Intracardiac Carcinoid Neuroendocrine Tumor: A Case Report. Psychosomatics 2018;59:607-11. [PMID: 29703550 DOI: 10.1016/j.psym.2018.03.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 54 |
Jensen RT. Gastrointestinal Neuroendocrine Tumor Syndromes (GI NETS). Encyclopedia of Endocrine Diseases 2018. [DOI: 10.1016/b978-0-12-801238-3.95870-7] [Reference Citation Analysis]
|
